[PDF][PDF] Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

…, A Tabachnikova, C Chang, L Walker, A Lansky… - Cancer cell, 2021 - cell.com
Immunotherapy is a mainstay of non-small cell lung cancer (NSCLC) management. While
tumor mutational burden (TMB) correlates with response to immunotherapy, little is known …

Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors

…, A Tabachnikova, S Keerthivasan, A Lansky… - Cancer Discovery, 2022 - AACR
The cellular and molecular programs driving T-cell marginalization in solid tumors remain
unclear. Here, we describe two CAF populations associated with T-cell exclusion in human …

[HTML][HTML] Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children

…, C Chang, R Marvin, S Calorossi, A Lansky… - Nature …, 2021 - nature.com
Multisystem inflammatory syndrome in children (MIS-C) presents with fever, inflammation
and pathology of multiple organs in individuals under 21 years of age in the weeks following …

[HTML][HTML] Sampling the host response to SARS-CoV-2 in hospitals under siege

…, R Marvin, DM Del Valle, S Calorossi, A Lansky… - Nature Medicine, 2020 - nature.com
To the Editor—Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the
resulting coronavirus disease 2019 (COVID-19) have stretched healthcare systems thin across …

[HTML][HTML] Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children

…, C Chang, R Marvin, S Calorossi, A Lansky… - Medrxiv, 2020 - ncbi.nlm.nih.gov
Multisystem inflammatory syndrome in children (MIS-C) presents with fever, inflammation
and multiple organ involvement in individuals under 21 years following severe acute …

CITEseq analysis of non-small-cell lung cancer lesions reveals an axis of immune cell activation associated with tumor antigen load and TP53 mutations

…, B Maier, A Tabachnikova, L Walker, A Lansky… - Biorxiv, 2020 - biorxiv.org
Immunotherapy is becoming a mainstay in the treatment of NSCLC. While tumor mutational
burden (TMB) has been shown to correlate with response to immunotherapy, little is known …

Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege

…, R Marvin, DM Del Valle, S Calorossi, A Lansky… - Nature Medicine, 2021 - nature.com
In the version of this article initially published, three accession numbers (EGAS00001004229,
EGAS00001004386 and EGAS00001004387) were missing from the Data Availability …

Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege

…, R Marvin, DM Del Valle, S Calorossi, A Lansky… - Nature Medicine, 2020 - nature.com
Alona Lansky … Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica
Le Berichel, Christie Chang, Robert Marvin, Diane Marie Del Valle, Sharlene Calorossi …

SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction (preprint)

…, R Heller, S Nietzsche, B Löffler, C Ehrhardt, A Lansky… - 2020 - pesquisa.bvsalud.org
Infections with SARS-CoV-2 lead to mild to severe coronavirus disease-19 (COVID-19) with
systemic symptoms. Although the viral infection originates in the respiratory system, it is …

Multiscale characterization of non-small-cell lung cancer identifies cellular determinants of tumor immunity

AM Leader - 2020 - search.proquest.com
Immunotherapy is becoming a mainstay in the treatment of NSCLC. However, there remains
a fundamental knowledge gap around the factors influencing the anti-tumor immune …